Sinco Pharmaceuticals Holdings Limited announced that Mr. Hao Jinghui has resigned as the co-chief executive officer of the Company, and has been appointed as a business and strategy advisor of the company. The company also announced that Mr. Wu Qing Jiang has been appointed as the co-chief executive officer of the Company. Upon the appointment, Mr. Wu and the current co-chief executive officer, Mr. Huang Xiangbin, will jointly serve as the co-chief executive officers of the Company, sharing the responsibility of the Group's overall business development, operation, and management work.

Effective date of change is 5 May 2017.